Amarin Corporation plc has announced the resignation of director Patrice Bonfiglio, effective immediately. This decision was made on November 16, 2026, and is not attributed to any disagreement regarding the company's operations or policies.
Amarin Corp, a company based in Dublin, Ireland, specializes in pharmaceutical preparations. It is listed on the Nasdaq under the ticker symbol AMRN. The company has been active in the pharmaceutical industry, focusing on innovative solutions for cardiovascular health.
The filing indicates that Ms. Bonfiglio's resignation is a personal decision, and it does not specify any immediate successor or additional changes to the board. The impact of her departure on Amarin's strategic direction remains to be seen, particularly as the company navigates its ongoing initiatives in the competitive pharmaceutical landscape.
As the pharmaceutical industry continues to evolve, leadership changes like this can influence market dynamics. Amarin's competitors may seek to leverage any uncertainty during this transition period to strengthen their positions.
The filing does not specify what happens next regarding board appointments or strategic adjustments.
Company Overview
Amarin Corporation plc, incorporated in England and Wales, operates primarily in the pharmaceutical preparations sector, classified under the Standard Industrial Classification code 2834. The company is headquartered at Spaces South Docklands, Block C, 77 Sir John Rogerson's Quay, Dublin 2, Ireland, and its fiscal year ends on December 31.
Corporate Structure
Amarin was previously known as Amarin Pharmaceuticals PLC and Ethical Holdings PLC before its name change in February 2000. The company is registered with the SEC under file number 0-21392 and has a Central Index Key (CIK) of 0000897448.
Contact Information
For inquiries, Amarin can be reached at +353 1 6699 020, providing a direct line for stakeholders and interested parties to connect with the company.
The filing does not include any details regarding the potential impact of Ms. Bonfiglio's resignation on Amarin's ongoing projects or future strategic plans.
Read Next
Afsari Nasym acquires 68,235 shares of Onterris, Inc.
Onterris, Inc. Chief Strategy Officer Acquires Shares
StubHub Holdings' Mark Streams Sells 76,891 Shares
Francesca M. Edwardson Transfers 25,000 Shares to Trust
Fitzgerald sells 21,580 shares of StubHub Holdings stock
Zatlyn Michelle files recent executive transaction details




